Plasma concentration and protein binding of alfentanil during high-dose infusion for cardiac surgery.

We have studied plasma protein binding of alfentanil in 10 patients given a mean total dose of 949 micrograms kg-1 as the principal anaesthetic agent for coronary artery bypass grafting. The mean unbound fraction of plasma alfentanil increased from 0.09 to 0.16 after administration of heparin and to 0.26 after beginning cardiopulmonary bypass (CPB). After CPB until the end of surgery, the unbound fraction decreased to 0.12. These changes in the unbound fraction were associated with significant changes in plasma total and unbound concentrations of alfentanil also. Within the first 1 min of CPB, total alfentanil concentration had decreased by more than the unbound concentration and the decrease observed in the latter disappeared rapidly. From induction of anaesthesia until awakening of the patient, plasma protein binding of alfentanil was related significantly (P = 0.0166) to the serum concentration of orosomucoid (alpha 1-acid glyco-protein).

[1]  M. Wood.  Plasma binding and limitation of drug access to site of action. , 1991, Anesthesiology.

[2]  J. Mantz,et al.  High-dose alfentanil for myocardial revascularization: a hemodynamic and pharmacokinetic study. , 1991, Journal of Cardiothoracic and Vascular Anesthesia.

[3]  M. Pasque,et al.  Free and total lidocaine levels in cardiac surgical patients. , 1990, Journal of cardiothoracic anesthesia.

[4]  E. Mortier,et al.  Cardiopulmonary Bypass and the Pharmacokinetics of Drugs , 1989 .

[5]  E. L. Wright,et al.  Propofol—fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass , 1989, Anaesthesia.

[6]  R. Hall,et al.  Alfentanil plasma concentration v. effect relationships in cardiac surgical patients. , 1988, British journal of anaesthesia.

[7]  A. Bjorksten,et al.  The effects of cardiopulmonary bypass on plasma concentrations and protein binding of methohexital and thiopental. , 1988, Journal of cardiothoracic anesthesia.

[8]  P. Duvaldestin,et al.  Pharmacokinetics of alfentanil in children undergoing surgery. , 1987, British journal of anaesthesia.

[9]  M. Hynynen,et al.  Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Plasma opiate concentrations, haemodynamics and postoperative course. , 1986, British journal of anaesthesia.

[10]  D. Morgan,et al.  Thiopentone levels during cardiopulmonary bypass , 1986, Anaesthesia.

[11]  J. Bovill,et al.  Comparison of Fentanyl, Sufentanil, and Alfentanil Anesthesia in Patients Undergoing Valvular Heart Surgery , 1984, Anesthesia and analgesia.

[12]  T. Stanley,et al.  Alfentanil-Oxygen Anaesthesia for Coronary Artery Surgery , 1982 .

[13]  C. Hull,et al.  Comparative pharmacokinetics of fentanyl and alfentanil. , 1982, British journal of anaesthesia.

[14]  J. Heykants,et al.  Plasma protein binding and distribution of fentanyl, sufentanil, alfentanil and lofentanil in blood. , 1982, Archives internationales de pharmacodynamie et de therapie.

[15]  K. Giacomini,et al.  Administration of heparin causes in vitro release of non-esterified fatty acids in human plasma. , 1980, Life sciences.

[16]  T. Bjornsson,et al.  Diazepam and N‐desmethyldiazepam redistribution after heparin , 1980, Clinical pharmacology and therapeutics.

[17]  A. Wood,et al.  Propranolol Binding in Plasma during Cardiopulmonary Bypass , 1979, Anesthesiology.

[18]  B. Bull,et al.  Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. , 1975, The Journal of thoracic and cardiovascular surgery.

[19]  A. Burm,et al.  Pharmacodynamics of alfentanil. The role of plasma protein binding. , 1992, Anesthesiology.

[20]  F. Donati,et al.  Pharmacokinetics of alfentanil and clinical responses during cardiac surgery , 1990, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[21]  E. Mortier,et al.  Cardiopulmonary bypass and the pharmacokinetics of drugs. An update. , 1989, Clinical pharmacokinetics.

[22]  S. deLange,et al.  Alfentanil-oxygen anaesthesia: plasma concentrations and clinical effects during variable-rate continuous infusion for coronary artery surgery. , 1983 .